Patents by Inventor Raymond Y. Chan

Raymond Y. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200327501
    Abstract: A transaction management system includes an analysis module, analyzing a character requirement and a processing deadline of at least one transaction to be assigned, wherein the analysis module analyzes a working state of at least one character to obtain an available time, and an assignment module, communicatively connected with the analysis module to assign the character having available time before the processing deadline and meeting the character requirement to be at least one executor of the transaction.
    Type: Application
    Filed: February 20, 2020
    Publication date: October 15, 2020
    Inventors: Raymond Y. CHAN, Rihui CHEN, Xueguang DONG, Tiaowan LIU, Wei DU, Xiaoxiao DUAN
  • Publication number: 20200327479
    Abstract: A bidirectional selecting method, between service objects and service providers, includes the steps of: after acquiring an expression data about a user, acquiring at least intentional object in a corresponding object database based on the expression data and a background information of the user to obtain a processing result; and outputting the processing result, wherein when the user is a service object, the object database is a service provider database, wherein when the user is a service provider, the object database is a service object database.
    Type: Application
    Filed: February 20, 2020
    Publication date: October 15, 2020
    Applicant: David & Raymond Patent Firm
    Inventors: Raymond Y. CHAN, Rihui CHEN, Xueguang DONG, Tiaowan LIU, Wei DU, Xiaoxiao DUAN
  • Publication number: 20200327502
    Abstract: The present invention provides a project management method, which comprises the steps of: (A) analyzing a resource demand of the project according to a project view of at least a project; (B) analyzing an available time of the resources according to a resource view of at least a resource; (C) calling the resources to the project according to the resource demand and the available time of the resources.
    Type: Application
    Filed: February 20, 2020
    Publication date: October 15, 2020
    Inventors: Raymond Y. CHAN, Rihui CHEN, Xueguang DONG, Tiaowan LIU, Wei DU, Xiaoxiao DUAN
  • Publication number: 20200293560
    Abstract: A matching inventors method, for confirming the contribution made by each inventor can be conveniently, includes steps of: I. Obtaining one of claims form a specification; II. Translating said claim to obtain a discriminated code which presents said claim; and III. Pairing said discriminated code with at least one inventor preset in at least one inventors database to determine the contribution of said inventor to said claim.
    Type: Application
    Filed: February 20, 2020
    Publication date: September 17, 2020
    Inventors: Raymond Y. CHAN, Rihui CHEN, Xueguang DONG, Tiaowan LIU, Wei DU, Xiaoxiao DUAN
  • Patent number: 4657930
    Abstract: Disclosed are mitotic inhibitors effective for and methods of preventing posterior lens capsule opacification after extracapsular extraction. The mitotic inhibitors comprise osmotically balanced solutions containing either methotrexate or retinoic acid, or both, in at least the minimal effective dosage at the end of one lens epithelial cell cycle. The mitotic inhibitors are instilled in the anterior chamber of the eye preferably immediately after the lens has been removed.
    Type: Grant
    Filed: March 6, 1985
    Date of Patent: April 14, 1987
    Assignee: Baylor College of Medicine
    Inventors: Jared M. Emery, Raymond Y. Chan
  • Patent number: 4515794
    Abstract: Disclosed are mitotic inhibitors effective for and methods of preventing posterior lens capsule opacification after extracapsular extraction. The mitotic inhibitors comprise osmotically balanced solutions containing either methotrexate or retinoic acid, or both, in at least the minimal effective dosage at the end of one lens epithelial cell cycle. The mitotic inhibitors are instilled in the anterior chamber of the eye preferably immediately after the lens has been removed.
    Type: Grant
    Filed: July 20, 1983
    Date of Patent: May 7, 1985
    Assignee: Baylor College of Medicine
    Inventors: Jared M. Emery, Raymond Y. Chan